Has participated in:
-
It is time to move forward into the era of Theranostics
-
Radioligand therapy of metastatic castration-resistant prostate cancer: current approaches
-
Assessing the quality of life of patients with metastatic castration-resistant prostate cancer with bone metastases receiving [223Ra]RaCl2 therapy
-
Biodistribution and post-therapy dosimetric analysis of [177Lu]Lu-DOTAZOL in patients with osteoblastic metastases: first results